Literature DB >> 24018808

Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis.

Colin J R Stewart1, Michael D Walsh, Charley A Budgeon, Maxine L Crook, Daniel B Buchanan.   

Abstract

AIMS: The relationship between endometriosis and ovarian endometrioid adenocarcinoma (OEC) is well recognised but it is unclear whether endometriosis positive and negative OECs develop via similar pathogenetic mechanisms. MATERIALS: Sixty-seven low grade OECs (35 associated with endometriosis) were stained immunohistochemically for β-catenin, cyclin D1, BAF250a, PTEN, p53, WT1 and the mismatch repair (MMR) proteins MLH1, PMS2, MSH2 and MSH6. The results were correlated with KRAS mutation analysis and the presence of concurrent endometriosis.
RESULTS: Abnormal β-catenin, cyclin D1, BAF250a, PTEN, p53 and MMR protein expression was identified in 61.2%, 50.7%, 19.4%, 23.9%, 9.0%, and 6.0% of cases, respectively; these changes were equally common in endometriosis positive and negative tumours. WT1 expression was restricted to endometriosis negative EOC (8/32, 25%) and four WT1 positive cases showed sertoliform/spindle cell histological patterns. Abnormal β-catenin expression correlated with cyclin D1 overexpression but was inversely related to KRAS mutation. Immunophenotypic abnormalities were present in four of 17 histologically benign endometriotic lesions.
CONCLUSIONS: Most immunophenotypic alterations were equally common in endometriosis associated and independent OECs but only the latter were associated with abnormal WT1 expression. The inverse relationship between abnormal β-catenin expression and KRAS mutation merits further study. Histologically benign endometriotic epithelium may show immunophenotypic abnormalities similar to those present in associated carcinomas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24018808     DOI: 10.1097/PAT.0b013e3283650ad7

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

1.  MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma.

Authors:  Hai Ming Li; Jin Wei Qiang; Gan Lin Xia; Shu Hui Zhao; Feng Hua Ma; Song Qi Cai; Feng Feng; Ai Yan Fu
Journal:  J Ovarian Res       Date:  2015-04-30       Impact factor: 4.234

2.  Estradiol promotes cells invasion by activating β-catenin signaling pathway in endometriosis.

Authors:  Wenqian Xiong; Ling Zhang; Lan Yu; Wei Xie; Yicun Man; Yao Xiong; Hengwei Liu; Yi Liu
Journal:  Reproduction       Date:  2015-10-02       Impact factor: 3.906

3.  Predictive factors of endometriosis progression into ovarian cancer.

Authors:  Ján Varga; Alžbeta Reviczká; Hedviga Háková; Peter Švajdler; Miroslava Rabajdová; Alexander Ostró
Journal:  J Ovarian Res       Date:  2022-01-10       Impact factor: 4.234

4.  The prevalence of mismatch repair deficiency in ovarian cancer: A systematic review and meta-analysis.

Authors:  Amit Atwal; Tristan Snowsill; Marcus Cabrera Dandy; Thomas Krum; Claire Newton; Dafydd Gareth Evans; Emma J Crosbie; Neil A J Ryan
Journal:  Int J Cancer       Date:  2022-07-06       Impact factor: 7.316

5.  Non-target genetic manipulation induces rhabdomyosarcoma in KrasPten-driven mouse model of ovarian cancer.

Authors:  Huiling Lai; Yunyun Guo; Weipeng He; Tingting Sun; Linglong Ouyang; Liming Tian; Yuanyuan Li; Xiaohui Li; Zeshan You; Guofen Yang
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.